Morning Overview on MSN
Women on weight-loss drugs had 35% lower breast-cancer odds in the full study group
Women taking GLP-1 receptor agonists, the class of drugs behind semaglutide and liraglutide, had 35.1 percent lower odds of ...
Recent research has overturned the idea that self-critical behavior fosters resilience. An innovative study demonstrated that ...
SALVOVAR: A pragmatic randomized phase III trial comparing the salvage weekly dose-dense regimen to the standard 3-weekly regimen in patients with poor prognostic ovarian cancers (GINECO-OV130b; ENGOT ...
Malaria control and elimination is threatened by the spread of insecticide resistance and behavioral adaptation of vectors. Whether mass administration of ivermectin, a broad-spectrum antiparasitic ...
Ruxolitinib in Patients With Corticosteroid-Refractory or Corticosteroid-Dependent Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of the Phase III REACH3 Study PD-1 immune checkpoint ...
Arialys Announces First ANRE Patient Treated with ART5803 in Open-Label Phase 2 Study and FDA Clearance of IND for Randomized Phase 2 Study ...
For more than three decades, researchers Christine Stabell Benn and Peter Aaby from the Bandim Health Project have conducted randomized trials involving thousands of children in Guinea-Bissau and ...
Objective To assess the effectiveness of low tendon compression rehabilitation (LTCR) versus high tendon compression rehabilitation (HTCR) for treating patients with insertional Achilles tendinopathy.
Medical research shapes healthcare every day, but not all studies are created equal. Knowing the differences can help you feel more confident reading health information online and understanding what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results